Article Text

Ethical aspects of new medicines targeted at treatment of RA
  1. C GARCIA-PORRÚA,
  2. M A GONZÁLEZ-GAY
  1. Rheumatology Division
  2. Hospital Xeral-Calde
  3. Lugo, Spain
  1. Dr M A González-Gay, Section of Rheumatology, Hospital Xeral-Calde Lugo, c/ Dr. Ochoa s/n, 27004 Lugo, Spain miguelaggay{at}hotmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the article reported by Kreutzet al “European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritis”.1 The use of placebo studies for the development of new medicines in patients with rheumatoid arthritis (RA) remains controversial.2 Placebo studies are useful when testing …

View Full Text

Footnotes

  • Dr García-Porrúa is a member of the Galician ethical committee for clinical investigation (northwestern Spain).